Hays, Seth A.
Rennaker, Robert L.
Kilgard, Michael P.
Article History
Received: 17 January 2025
Accepted: 18 January 2025
First Online: 3 February 2025
Competing interests
: MPK has a financial interest in MicroTransponder Inc., which markets VNS therapy for stroke. RLR is the founder and CEO of XNerve, which develops a VNS system. SAH has nothing to declare.